Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Considering And Approving Unaudited Stand-Alone And Consolidated Financial Results Of The Company For The Quarter / Half Year Ended September 30, 2022.
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Inter alia, to consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter / half year ended September 30, 2022 and to consider and decide on payment of Interim Dividend, if any, for the financial year 2022-23.02-11-2022
